BioSpace News Archive

Surrozen, Inc. today announced that Craig Parker, Chief Executive Officer, will present at the Stifel 2021 Virtual Healthcare Conference at 4:40 p.m. ET on Tuesday, November 16.

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced the granting of inducement awards to 15 new employees.

UCB, a global biopharmaceutical company, announced new data on its investigational IL-17A and IL-17F inhibitor, bimekizumab, and its TNF inhibitor, CIMZIA®.

Iterum Therapeutics plc today announced that the Company will release its third quarter 2021 financial results before the open of the U.S. financial markets on Friday, November 12, 2021.

MannKind Corporation will present data at the 21st Annual Diabetes Technology Meeting.

IsoPlexis Corporation today announced that data generated on its IsoLight® and IsoSpark® Platforms will be presented at the 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), on November 11th

Hillrom (NYSE: HRC) today announced financial results for its fiscal fourth quarter and full-year ended September 30, 2021 .

Epizyme, a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, announced that the Company approved the grant of equity awards to a new employee with a grant date of November 1, 2021, as equity inducement awards outside of the Company’s 2013 Stock Incentive Plan and material to the employee’s acceptance of employment with the Company.

Sierra Oncology, Inc. today reported its financial and operating results for the third quarter ended September 30, 2021.

The increased health consciousness among people leads to the demand for smart devices to monitor their health records.